Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2009-06-15
Original SEC Filing: Click here

---

Webplus: BSPM/20090615/8-K/2_EX-99.1_CHARTER/000.htm SEC Original: ex99-1.htm
Biostar Pharmaceuticals, Inc. Retains HC International, Inc. to Implement Investor Relations Program NEW YORK and Xianyang, China, The Company’s flagship product is the Xin Ao Xing Oleanolic Acid Capsule, the only SFDA approved OTC drug from the local level to the state level which treats chronic hepatitis B, a condition which affects 10% of the Chinese population. In addition, the

---

---

Webplus: BSPM/20090615/8-K/1/000.htm SEC Original: biostar8-k06152009.htm
FORM 8-K CURRENT REPORT June 15, 2009 Date of Report (Date of earliest event reported): BIOSTAR PHARMACEUTICALS, INC. Maryland 333-147363 20-5101287 (State or other jurisdiction of incorporation) (Commission Fil e Number) (IRS Employer Identification No.) Province, No. 588 Shiji Avenue, Xiangyang City, Shaanxi The People’s Republic of China 712046 (Zip Code) 86- 029-33686638 Benjamin Tan, Esq. Sichenzia Ross Friedman Ference

---

Company Information:

Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2009-06-15CIK: 0001418133, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 588 SHIJI XI AVENUE
XIANYANG, SHAANXI PROVINCE 712046